Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study
Authors:
Abstract
Background: Interferon-induced depression represents a major complication in antiviral treatment of chronic hepatitis C virus (HCV) infection. Aim: To evaluate in a placebo-controlled study the efficacy of a selective serotonin reuptake inhibitor (SSRI) in HCV patients on antiviral therapy with interferon-associated depression. Methods: 100 HCV outpatients were included in a randomised, double-blind, placebo-controlled study. During interferon therapy (peginterferon alfa-2b plus ribavirin), depression was monitored using the Hospital Anxiety and Depression Scale (HADS). Patients with clinically relevant interferon-induced depression (HADS ⩾9) were randomly assigned to placebo or citalopram (SSRI, 20 mg/day). Results: In 28 patients (28%), HADS scores increased to >8 during interferon therapy. They were treated with placebo (n = 14) or SSRI (n = 14). HADS scores declined significantly in SSRI patients within four weeks of therapy (pConclusions: The findings demonstrate clearly that citalopram treatment is highly effective in HCV patients on interferon therapy, when initiated after the onset of clinically relevant depressive symptoms. This suggests that a general SSRI prophylaxis is not necessary in these patients.Keywords
This publication has 30 references indexed in Scilit:
- Depression, anemia and health-related quality of life in chronic hepatitis CJournal of Hepatology, 2006
- Cytokines sing the blues: inflammation and the pathogenesis of depressionTrends in Immunology, 2006
- Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CJournal of Hepatology, 2005
- Interferon-induced depression: Strategies in treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Interferon-induced depression: prevalence and managementDigestive and Liver Disease, 2005
- The phenomenology and treatment of interferon-induced depressionJournal of Affective Disorders, 2004
- Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective studyGeneral Hospital Psychiatry, 2003
- Forschungsmethoden und Evaluation2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Epidemiology of hepatitis CHepatology, 1997